Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

CHIPTS Center Co-Director, Dr. Raphael J. Landovitz, was part of this study that was published in JAMA online on March 12th titled, “Antiretroviral Drugs for Treatment and Prevention
of HIV Infection in Adults.”

Below is an excerpt from the published study. To see the full publication, click here to visit JAMA for the official e-publication or download the pdf here: 

New drugs and new approaches to prevent and manage HIV infection necessitate an update to the International Antiviral (formerly AIDS) Society–USA (IAS-USA) recommendations, last published in 2016.1 This report incorporates current data on new regimens and new approaches into recommendations for the treatment and prevention of HIV.

Recommendations were developed by an international panel of 16 volunteer experts in HIV research and care. Members were screened for expertise, involvement in research and care, financial relationships, and ability to work toward consensus (ie, ability to consider all available data, evidence, and group discussions or opinions to reach agreement on recommendations). The panel convened in person (N =2) and by conference calls (N = 10 full-panel and multiple subgroup calls) from September 2017 to June 2018. Teams for each section evaluated relevant evidence and drafted recommendations for full-panel review.